Rhizostin (sodium risedronate) coated tablets 35 mg. №4

$31.00

Treatment of postmenopausal osteoporosis: to reduce the risk of vertebral fractures. Treatment of confirmed postmenopausal osteoporosis to reduce the risk of hip fractures. Treatment of osteoporosis in men with a high risk of fractures.

Category: Manufacturer: Canada

Description

Release form, composition
The drug Rhizostin is produced in the form of orange-coated tablets, on the one hand tablets imprint “RS”, on the other – “35”.
The composition of 1 tablet includes the active ingredient: risedronic acid sodium (35 mg). Additional substances: colloidal silicon dioxide, mannitol, maltodextrin, povidone, sodium starch, corn starch, sodium stearyl fumarate and anhydrous ethanol.
1 blister with 4 tablets is packed in one pack.

Pharmacological properties
Rhizostin refers to drugs that affect bone mineralization and structure. Osteoporosis leads to a decrease in bone mass, which is the cause of an increased risk of fractures of the neck of the hip, spine and wrist. This disease can occur in both men and women, especially during menopause. The use of the drug helps to reduce the level of bone resorption, increase the mineral density of bone tissue.

Indications for use
Rhizostin is used and prescribed to treat postmenopausal osteoporosis to reduce the risk of vertebral and femoral fractures, as well as osteoporosis in men at high risk of fractures.

Contraindications
The drug Rhizostin has almost no contraindications. Do not use the drug in severe renal failure, hypocalcemia, hypersensitivity to the components and in childhood.

Pregnancy and breastfeeding
The use of the drug Rhizostin in pregnant women and nursing mothers is contraindicated.

Method of application
The drug Rhizostin is intended for oral administration.
The recommended dose is 35 mg (1 tablet) once a week.
The tablets are taken on the same day of the week, half an hour before meals, on an empty stomach, without chewing, drinking plenty of water. While taking the drug and 30 minutes after, the patient should be in an upright position.

Overdose
No cases of Rizostin overdose have been reported. At intoxication with drug development of signs of a hypocalcemia and decrease in calcium in blood is possible.
As a treatment, the patient can be given antacids or milk, if more than half an hour has passed since the overdose, it is recommended to rinse the stomach.

Adverse reactions
The use of the drug Rhizostin can lead to side effects such as:
headache, liver dysfunction, joint, muscle and bone pain, dyspepsia, constipation, nausea, diarrhea, duodenitis, abdominal pain, esophagitis, dysphagia, gastritis, esophageal ulcers, uveitis and inflammation of the iris.
Taking the drug can cause: decreased levels of phosphates and calcium,
hypersensitivity reactions and skin reactions, including angioneurotic edema, urticaria, generalized rash.
Also possible: osteonecrosis of the lower jaw, diaphyseal fractures and atypical femoral sciatica, hair loss and anaphylactic reactions.
In the event of any adverse reactions, it is necessary to cancel the drug and consult a doctor for further use.

Storage conditions
Rhizostin should be stored at a temperature not exceeding +30 ° C, in the original package, without moisture, direct sunlight and access to children. Shelf life is 5 years. The drug is released from pharmacies by prescription.